The COVID-19 pandemic poses a critical challenge to individuals, caregivers and healthcare systems worldwide. This challenge extends directly to the pharmaceutical industry where the most important priority remains the development and mass delivery of safe and effective vaccines and therapeutic solutions to stem the escalating morbidity and mortality associated with SARS-CoV-2 infections. PRA is the healthcare intelligence partner of choice during the COVID-19 pandemic, offering end-to-end solutions for research, clinical development, real-world data analysis and post-authorization safety management.

Pharmacovigilance & Patient Safety Solutions in Response to COVID-19

Explore related content and topics